SYNRIBO (omacetaxine mepesuccinate) for Injection is used for the treatment of patients with chronic myeloid leukemia (CML)

SYNRIBO for Injection is indicated for the treatment of adult patients with chronic or accelerated phase chronic myeloid leukemia (CML) with resistance and/or intolerance to two or more tyrosine kinase inhibitors (TKI). This indication is based upon response rate. There are no trials verifying an improvement in disease-related symptoms or increased survival with SYNRIBO.

SYNRIBO (omacetaxine mepesuccinate) for Injection suppliers in India. Indian Pharma Network (IPN) New Delhi, INDIA.

IPN is a facilitator under Patient Assistance Programs. Expertise in Specialty Pharmaceutical distribution having its PAN India presence in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, lucknow, north East and Pune and other cities in India. with over 20 years of domain experience.

For procurement cost of SYNRIBO (omacetaxine mepesuccinate) for Injection brand in India, sold by indian drug manufacturer. Please call at M: +91 9811747774 (Mr. Tarun) / 9891296838 (Mr. Neeraj) or Email Us to know more details about the SYNRIBO (omacetaxine mepesuccinate) for Injection medicine cost price in India.

The order for SYNRIBO (omacetaxine mepesuccinate) for Injection will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.

Omacetaxine mepesuccinate is a cephalotaxine-derived alkaloid ester obtained from Cephalotaxus harringtonia; used for the treatment of chronic or accelerated phase chronic myeloid leukaemia. It has a role as an antineoplastic agent, a protein synthesis inhibitor and an apoptosis inducer.

SYNRIBO™ (omacetaxine mepesuccinate) for Injection, for subcutaneous use Initial U.S. Approval: 2012

Generic Name: omacetaxine mepesuccinate

Single-use vial containing 3.5 mg of omacetaxine mepesuccinate as a lyophilized powder. .

Synribo (omacetaxine mepesuccinate) for Injection

SYNRIBO (omacetaxine mepesuccinate) for Injection is available.

Get In Touch

Indian Pharma Network (IPN), Delhi. India

IPN, Delhi is registered organisation in India, having highly qualified healthcare professionals of pharmaceutical Industry. Specialized in Oncology Products. Helped more than 6,000 patients. Registration Number : 07AAFFI2544E1ZO under GST Act. On the basis of permission in Form 12B (Import permit) from From Ministry of Health, Government of India. IPN, New Delhi helps patient, providing solutions on how to get access of anti cancer medicines which is not available in India.

BRANCH OFFICE : NEW DELHI | BENGALURU | KOLKATA | LUCKNOW | JODHPUR

Our Overseas Network UK | Russia | Brazil | Mexico | Germany | France| Italy | Spain | Japan | China| Australia | Saudi Arabia | South Africa

Indian Pharma Network

60/4 1st Floor, T&T Building, Indian Oil Complex,
Yusuf Sarai, New Delhi, Delhi 110016

Mobile / WhatsApp / Phone

M: +91 9811747774, 9891296838.
P: +91-11-26532129 / 26536398

Free Customer Support

info@indianpharmanetwork.co.in
urgent@indianpharmanetwork.co.in

SYNRIBO (omacetaxine mepesuccinate) for Injection suppliers in India

IPN helps patients, doctors and hospitals as a facilitator to import prescription medicine brand SYNRIBO (omacetaxine mepesuccinate) for Injection on prescription and Import License in Patient's Name only.

For overseas patients, SYNRIBO (omacetaxine mepesuccinate) for Injection can be made available in Send your enquiry to find SYNRIBO (omacetaxine mepesuccinate) for Injection in China, Cambodia, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong. UAE Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela. Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia. Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand.

News / Update for SYNRIBO (omacetaxine mepesuccinate) for Injection.

For SYNRIBO (omacetaxine mepesuccinate) for Injection Indications And Usage, Dosage And Administration, Dosage Forms And Strengths and Drug Interactions For More Details

FDA Approves Omacetaxine (Synribo) for CML For More Details

Teva Receives FDA Approval For Leukemia Treatment For Injection For More Details